A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication

被引:0
|
作者
Krasuski, R. A. [1 ]
Tobore, T. [2 ]
Studer, S. [2 ,3 ]
Jansa, P. [4 ,5 ]
Sitbon, O. [6 ]
Hoeper, M. M. [7 ,8 ]
Channick, R. N. [9 ]
Gaine, S. [10 ]
Lang, I. M. [11 ,12 ]
Chin, K. M. [13 ]
Pulido, T. [14 ]
Mehta, S. [15 ]
Torbicki, A. [16 ]
Sastry, B. [17 ]
Tang, X. [2 ]
McLaughlin, V. [18 ]
Reardon, L. [19 ]
机构
[1] Duke Univ Hlth Syst, Durham, NC USA
[2] Actel Pharmaceut US Inc, Titusville, NJ USA
[3] Johnson & Johnson, Janssen Pharmaceut Co, Titusville, NJ USA
[4] Charles Univ Prague, Prague, Czech Republic
[5] Gen Univ Hosp, Prague, Czech Republic
[6] Univ Paris Saclay, Hop Bicetre, AP HP, Le Kremlin Bicetre, France
[7] Hannover Med Sch, Hannover, Germany
[8] German Ctr Lung Res DZL, Hannover, Germany
[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[10] Mater Misericordiae Univ Hosp, Dublin, Ireland
[11] Med Univ Vienna, Cardiol, Vienna, Austria
[12] Med Univ Vienna, Ctr Cardiovasc Med, Vienna, Austria
[13] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX USA
[14] Natl Heart Inst, Mexico City, DF, Mexico
[15] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[16] ECZ Otwock, European Hlth Ctr, Ctr Postgrad Med Educ, Otwock, Poland
[17] CARE Hosp, Hyderabad, Telangana, India
[18] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[19] Univ Calif Los Angeles, Ahmanson UCLA Adult Congenital Heart Dis Ctr, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6460
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
    Ferrari, Pisana
    Armstrong, Iain
    Aldrighetti, Rino
    Howard, Luke
    Ryftenius, Henrik
    Fischer, Aryeh
    Lombardi, Sandra
    Studer, Sean
    Guillevin, Loic
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [42] Commentary on Symptom Experience of Pulmonary Arterial Hypertension (PAH) Patients
    Khan, Ehsan Ullah
    CLINICAL NURSING RESEARCH, 2011, 20 (02) : 135 - 143
  • [43] USE OF PAH SPECIFIC THERAPY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A META-ANALYSIS
    Shujaat, Adil
    Filopei, Jason
    Steiger, David
    CHEST, 2018, 154 (04) : 1046A - 1046A
  • [44] Effect of selexipag on long-term outcomes in patients with pulmonary arterial hypertension (PAH) receiving one, two or no PAH therapies at baseline: results from the GRIPHON study
    Lang, I.
    Gaine, S.
    Galie, N.
    Ghofrani, H. A.
    Le Brun, F. O.
    McLaughlin, V.
    Rubin, L. J.
    Simonneau, G.
    Sitbon, O.
    Hoeper, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 381 - 382
  • [45] The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH
    Clements, Philip J.
    Tan, Mary
    McLaughlin, Vallerie V.
    Oudiz, Ronald J.
    Tapson, Victor F.
    Channick, Richard N.
    Rubin, Lewis J.
    Langer, Anatoly
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) : 249 - 252
  • [46] Pulmonary vasodilator therapies in pulmonary arterial hypertension associated with CHD: a systematic review and network meta-analysis
    Yasuhara, Jun
    Watanabe, Kae
    Watanabe, Atsuyuki
    Shirasu, Takuro
    Matsuzaki, Yuichi
    Watanabe, Hirofumi
    Takagi, Hisato
    Sumitomo, Naokata
    Kuno, Toshiki
    CARDIOLOGY IN THE YOUNG, 2023, 33 (11) : 2297 - 2311
  • [47] Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry
    Skride, Andris
    Sablinskis, Kristaps
    Lejnieks, Aivars
    Rudzitis, Ainars
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 36 : E20 - E21
  • [48] Differences In Physical Activity Level Between The Congenital Heart Disease Associated PAH And Idiopathic PAH
    Acar, Serap
    Akdeniz, Bahri
    Ozcan, Buse
    Karadibak, Didem
    Ozpelit, Ebru
    Sevinc, Can
    Savci, Sema
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2015, 47 (05): : 635 - 635
  • [49] The Use Of Pah Specific Therapy In Sarcoidosis Associated Pulmonary Hypertension (saph): a Meta-Analysis And Systematic Review
    Shujaat, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [50] Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc)
    Jiang, Yuxuan
    Turk, Matthew A.
    Pope, Janet E.
    AUTOIMMUNITY REVIEWS, 2020, 19 (09)